ReviewFrontiers in immunology2023

PD-1 and PD-L1: architects of immune symphony and immunotherapy breakthroughs in cancer treatment.

Adil Parvez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.